Bolivia vs Jamaica: Access to anti-retroviral drugs, female (%)
Bolivia
62.0%
in 2024
Jamaica
62.0%
in 2024
Bolivia rank
99th
Jamaica rank
99th
Access to anti-retroviral drugs, female (%) over time
- Bolivia
- Jamaica
How they compare
Bolivia currently reports 62.0% against 62.0% in Jamaica, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Jamaica ahead.
Bolivia ranks 99th and Jamaica ranks 99th of 141 countries.
Jamaica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bolivia | Jamaica | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.1% | 5.8% | 3.7% | Jamaica |
| 2010s | 29.4% | 39.5% | 10.1% | Jamaica |
| 2020s | 57.6% | 59.0% | 1.4% | Jamaica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Bolivia or Jamaica?
- Bolivia, at 62.0% against 62.0% in Jamaica as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Bolivia and Jamaica?
- 0.0%, with Bolivia ahead.
- How many years of comparable data are there for Bolivia and Jamaica?
- 25 years are reported by both, from 2000 to 2024.
- How do Bolivia and Jamaica rank globally for access to anti-retroviral drugs, female?
- Bolivia ranks 99th and Jamaica ranks 99th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.